NCT06284187

Brief Summary

BACKGROUND: Pulmonary tuberculosis remains the leading cause of morbidity and mortality in Thailand. The microbiological detection of TB is important because of early and correct diagnosis, drug resistance testing and ensures that the effective treatment can be achieved and in a timely manner. Mycobacterial culture is the gold standard diagnostic test. Currently, a real-time polymerase chain reaction (RT-PCR) assay, such as Allplex™ MTB/MDRe Detection, Seegene is commonly used. OBJECTIVE: To evaluate the diagnosis value of the real-time multiplex PCR by using Allplex™ MTB/MDRe Detection kit to detect MTB from sputum specimens with a gold standard TB culture.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 19, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 28, 2024

Completed
Last Updated

February 28, 2024

Status Verified

February 1, 2024

Enrollment Period

10 months

First QC Date

February 19, 2024

Last Update Submit

February 27, 2024

Conditions

Keywords

pulmonary tuberculosisreal-time PCRdiagnosis test

Outcome Measures

Primary Outcomes (1)

  • Number of participants with pulmonary TB by Allplex™ MTB/MDRe

    Laboratory parameter

    From enrollment to the end of diagnosis at 1 week

Eligibility Criteria

Age15 Years+
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

out patients clinic

You may qualify if:

  • Clinical suspected pulmonary M. tuberculosis infection
  • Aged 15 years and older

You may not qualify if:

  • Children under 15 years old
  • Non-tuberculous mycobacteria (NTM) detection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thananit Sangkomkamhang

Khon Kaen, 40000, Thailand

Location

MeSH Terms

Conditions

TuberculosisTuberculosis, Pulmonary

Condition Hierarchy (Ancestors)

Mycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsRespiratory Tract InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Kriengsak Vacharanukulkieti, Medicine

    Khon Kaen Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Hospital

Study Record Dates

First Submitted

February 19, 2024

First Posted

February 28, 2024

Study Start

January 1, 2023

Primary Completion

October 31, 2023

Study Completion

December 31, 2023

Last Updated

February 28, 2024

Record last verified: 2024-02

Locations